Tuesday, March 6, 2012

Potential New Target To Counteract Brain Tumor Resistance To Therapy

Persistent protein expression may explain why tumors return after therapy in glioblastoma patients, according to a study published in the Journal of Experimental Medicine. Current therapy for glioblastoma, the most prevalent malignant brain tumor in adults, includes targeting a protein called VEGF, which promotes the growth of blood vessels to the tumor...





No comments:

Post a Comment